Advanced search
Publication Cover
Applied Economics Letters Volume 10, 2003 - Issue 8
Submit an article Journal homepage
264
Views
22
CrossRef citations to date
0
Altmetric
Original Articles

The relationship between price regulation and pharmaceutical profit margins

John A. Vernon Department of Healthcare Management, The Wharton School, University of Pennsylvania and the Department of Finance, Baldwin-Wallace College, Graduate School of Business Administration, 275 Eastland Road, Berea, Ohio 44017-2088, USA E-mail: [email protected]
Pages 467-470 | Published online: 06 Oct 2010

Citations (22)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Dimitrios Kourouklis, Mikel Berdud, Mireia Jofre-Bonet & Adrian Towse. (2023) Alternative funding models for medical innovation: the role of product development partnerships in product innovation for infectious diseases. Applied Economics Letters 30:16, pages 2195-2199.
Read now
Maria Angelica Borges dos Santos, Leticia Lucia dos Santos Dias, Cláudia Du Bocage Santos Pinto, Rondineli Mendes da Silva & Claudia Garcia Serpa Osorio-de-Castro. (2019) Factors influencing pharmaceutical pricing - a scoping review of academic literature in health science. Journal of Pharmaceutical Policy and Practice 12:1.
Read now
Travis J. Lybbert. (2007) Polarization & pricing to the rich. Applied Economics Letters 14:6, pages 389-394.
Read now

Articles from other publishers (19)

Andrea Sestino & Cesare Amatulli. (2021) Branded vs. Generic drugs: the role of self-perceived seriousness of disease. International Journal of Pharmaceutical and Healthcare Marketing 16:1, pages 22-39.
Crossref
Jörg Mahlich, Arne Bartol & Srirangan Dheban. (2021) Can adaptive clinical trials help to solve the productivity crisis of the pharmaceutical industry? - a scenario analysis. Health Economics Review 11:1.
Crossref
Mujaheed Shaikh, Pietro Del Giudice & Dimitrios Kourouklis. (2020) Revisiting the Relationship Between Price Regulation and Pharmaceutical R&D Investment. Applied Health Economics and Health Policy.
Crossref
Brita A.K. PekarskyBrita A. K. Pekarsky. 2015. The New Drug Reimbursement Game. The New Drug Reimbursement Game 37 57 .
Stephan Eger & Jörg C Mahlich. (2014) Pharmaceutical regulation in Europe and its impact on corporate R&D. Health Economics Review 4:1.
Crossref
Kristin Peterson. 2014. Speculative Markets. Speculative Markets 209 232 .
Kristin Peterson. 2014. Speculative Markets. Speculative Markets 185 208 .
Kristin Peterson. 2014. Speculative Markets. Speculative Markets 177 183 .
Kristin Peterson. 2014. Speculative Markets. Speculative Markets 155 176 .
Kristin Peterson. 2014. Speculative Markets. Speculative Markets 126 154 .
Kristin Peterson. 2014. Speculative Markets. Speculative Markets 103 125 .
Kristin Peterson. 2014. Speculative Markets. Speculative Markets 80 102 .
Kristin Peterson. 2014. Speculative Markets. Speculative Markets 53 79 .
Kristin Peterson. 2014. Speculative Markets. Speculative Markets 25 52 .
Kristin Peterson. 2014. Speculative Markets. Speculative Markets 1 23 .
Elias Mossialos, David Brogan & Tom Walley. (2006) Pharmaceutical Pricing in Europe: Weighing up the Options. International Social Security Review 59:3, pages 3-25.
Crossref
John A. Vernon, Joseph H. Golec & W. Keener Hughen. (2016) The Economics of Pharmaceutical Price Regulation and Importation: Refocusing the Debate. American Journal of Law & Medicine 32:2-3, pages 175-192.
Crossref
John A. Vernon. (2004) Examining the link between price regulation and pharmaceutical R&D investment. Health Economics 14:1, pages 1-16.
Crossref
Krzysztof I. Rybinski, Stanislaw Alwasiak, Oskar Kowalewski, Monika Lewandowska-Kalina & Michaa Mooddee. (2013) Rola Grup Interessw W Procesie Stanowienia Prawa W Polsce (The Role of Groups of Interest in the Legislation Process in Poland). SSRN Electronic Journal.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.